• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋病奈瑟菌在耐氟喹诺酮类药物的分离株中,gyrA和parC的类似区域会发生突变。

Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.

作者信息

Belland R J, Morrison S G, Ison C, Huang W M

机构信息

Laboratory of Microbial Structure and Function, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana 59840.

出版信息

Mol Microbiol. 1994 Oct;14(2):371-80. doi: 10.1111/j.1365-2958.1994.tb01297.x.

DOI:10.1111/j.1365-2958.1994.tb01297.x
PMID:7830580
Abstract

Neisseria gonorrhoeae homologues of gyrA and parC have been identified using hybridization probes generated from conserved regions of diverse gyrA genes. These genes have been tentatively identified as gyrA and parC, based on predicted amino acid sequence homologies to known GyrA homologues from numerous bacterial species and to ParC from Escherichia coli and Salmonella typhimurium. The gyrA gene maps to a physical location distant from the gyrB locus on the gonococcal chromosome, which is similar to the situation found in E. coli. The parC gene is not closely linked (i.e. greater than 9 kb) to an identifiable parE gene in N. gonorrhoeae. The gonococcal GyrA is slightly larger than its E. coli homologue and contains several small insertions near the C-terminus of the predicted open reading frame. A series of ciprofloxacin-resistant mutants were selected by passage of N. gonorrhoeae on increasing concentrations of the antibiotic. Sequential passage resulted in the selection of isolates with minimum inhibitory concentrations approximately 10,000-fold higher than the parental strain. Mutations within gyrA resulted in low to moderate levels of resistance, while strains with high-level resistance acquired analogous mutations in both gyrA and parC. Resistance mutations were readily transferred between N. gonorrhoeae strains by transformation. The frequencies of transformation, resulting in different levels of ciprofloxacin resistance, further support the notion that both gyrA and parC genes are involved in the establishment of extreme levels of ciprofloxacin resistance.

摘要

利用从多种gyrA基因保守区域生成的杂交探针,已鉴定出淋病奈瑟菌的gyrA和parC同源物。基于与众多细菌物种已知的GyrA同源物以及大肠杆菌和鼠伤寒沙门氏菌的ParC预测氨基酸序列同源性,这些基因已被初步鉴定为gyrA和parC。gyrA基因定位于淋球菌染色体上与gyrB基因座距离较远的物理位置,这与在大肠杆菌中发现的情况相似。parC基因在淋病奈瑟菌中与可识别的parE基因没有紧密连锁(即大于9 kb)。淋病奈瑟菌的GyrA比其大肠杆菌同源物略大,并且在预测的开放阅读框的C末端附近包含几个小的插入片段。通过在浓度不断增加的抗生素上传代淋病奈瑟菌,选择了一系列对环丙沙星耐药的突变体。连续传代导致选择出最低抑菌浓度比亲本菌株高约10,000倍的分离株。gyrA内的突变导致低至中等水平的耐药性,而具有高水平耐药性的菌株在gyrA和parC中都获得了类似的突变。耐药突变通过转化很容易在淋病奈瑟菌菌株之间转移。导致不同水平环丙沙星耐药性的转化频率进一步支持了gyrA和parC基因都参与建立极端水平环丙沙星耐药性的观点。

相似文献

1
Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.淋病奈瑟菌在耐氟喹诺酮类药物的分离株中,gyrA和parC的类似区域会发生突变。
Mol Microbiol. 1994 Oct;14(2):371-80. doi: 10.1111/j.1365-2958.1994.tb01297.x.
2
In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.体外筛选携带DNA促旋酶和拓扑异构酶IV改变的耐氟喹诺酮淋病奈瑟菌。
J Urol. 2000 Sep;164(3 Pt 1):847-51. doi: 10.1097/00005392-200009010-00060.
3
Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.1995年至1998年在丹麦分离出的淋病奈瑟菌菌株中高水平环丙沙星耐药性的分子基础。
Antimicrob Agents Chemother. 2001 Jan;45(1):117-23. doi: 10.1128/AAC.45.1.117-123.2001.
4
Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.天然存在的喹诺酮耐药淋病奈瑟菌菌株对新型喹诺酮类药物的体外敏感性与GyrA和ParC变化的相关性
Antimicrob Agents Chemother. 2001 Mar;45(3):734-8. doi: 10.1128/AAC.45.3.734-738.2001.
5
Development of fluoroquinolone resistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan.日本淋病奈瑟菌分离株中氟喹诺酮耐药性的发展以及涉及GyrA和ParC蛋白的突变
J Urol. 1998 Jun;159(6):2215-9. doi: 10.1016/S0022-5347(01)63308-1.
6
Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.关于parC突变在大肠杆菌高水平氟喹诺酮耐药性形成中作用的遗传学证据。
Antimicrob Agents Chemother. 1996 Apr;40(4):879-85. doi: 10.1128/AAC.40.4.879.
7
Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro.淋病奈瑟菌分离株喹诺酮耐药机制的体外分析。
Sex Transm Infect. 1998 Feb;74(1):59-62. doi: 10.1136/sti.74.1.59.
8
Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.肺炎链球菌编码DNA拓扑异构酶IV的parC和parE基因的克隆与特性分析:在氟喹诺酮耐药性中的作用
J Bacteriol. 1996 Jul;178(14):4060-9. doi: 10.1128/jb.178.14.4060-4069.1996.
9
Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae.淋病奈瑟菌喹诺酮耐药菌株中gyrA、gyrB、parC和parE的突变
APMIS. 2002 Sep;110(9):651-7. doi: 10.1034/j.1600-0463.2002.1100909.x.
10
gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.肯尼亚淋病奈瑟菌氟喹诺酮耐药株中 gyrA 和 parC 突变。
BMC Microbiol. 2019 Apr 8;19(1):76. doi: 10.1186/s12866-019-1439-1.

引用本文的文献

1
The frequency of mutations in the A, R, A and C genes of , the presence of M gene and antibiotic resistance/susceptibility: a systematic review and meta-analyses.[某种生物]的A、R、A和C基因中的突变频率、M基因的存在情况以及抗生素耐药性/敏感性:一项系统综述和荟萃分析。
Front Microbiol. 2025 Jan 22;15:1414330. doi: 10.3389/fmicb.2024.1414330. eCollection 2024.
2
Zap the clap with DNA: a novel microbicide for preventing infection.用 DNA 消灭淋病:一种新型杀微生物剂预防 感染。
Antimicrob Agents Chemother. 2024 Oct 8;68(10):e0079424. doi: 10.1128/aac.00794-24. Epub 2024 Aug 16.
3
Interactions between Zoliflodacin and Gyrase and Topoisomerase IV: Enzymological Basis for Cellular Targeting.
唑利福定与拓扑异构酶 II 和拓扑异构酶 IV 的相互作用:细胞靶向的酶学基础。
ACS Infect Dis. 2024 Aug 9;10(8):3071-3082. doi: 10.1021/acsinfecdis.4c00438. Epub 2024 Jul 31.
4
Target-Mediated Fluoroquinolone Resistance in : Actions of Ciprofloxacin against Gyrase and Topoisomerase IV.氟喹诺酮类药物的靶向耐药性:环丙沙星对拓扑异构酶 II 和拓扑异构酶 IV 的作用。
ACS Infect Dis. 2024 Apr 12;10(4):1351-1360. doi: 10.1021/acsinfecdis.4c00041. Epub 2024 Mar 4.
5
Gyrase and Topoisomerase IV: Recycling Old Targets for New Antibacterials to Combat Fluoroquinolone Resistance.回旋酶和拓扑异构酶 IV:回收旧靶点用于新型抗菌药物以对抗氟喹诺酮耐药性。
ACS Infect Dis. 2024 Apr 12;10(4):1097-1115. doi: 10.1021/acsinfecdis.4c00128. Epub 2024 Apr 2.
6
Antimicrobial resistance and molecular characteristics of isolates in Ghana.加纳分离株的抗菌药物耐药性及分子特征
Access Microbiol. 2024 Feb 8;6(2). doi: 10.1099/acmi.0.000689.v3. eCollection 2024.
7
Molecular epidemiological and antimicrobial-resistant mechanisms analysis of prolonged collection between 1971 and 2005 in Japan.日本1971年至2005年长期收集样本的分子流行病学及抗菌耐药机制分析
JAC Antimicrob Resist. 2024 Mar 12;6(2):dlae040. doi: 10.1093/jacamr/dlae040. eCollection 2024 Apr.
8
Phenotypic and Genotypic Antimicrobial Susceptibility Testing of Isolates from Patients with Persistent or Clinical Treatment Failure in Spain.西班牙持续性感染或临床治疗失败患者分离菌株的表型和基因型抗菌药物敏感性检测
Antibiotics (Basel). 2023 May 28;12(6):975. doi: 10.3390/antibiotics12060975.
9
gyrA Mutations in Mycoplasma genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy.支原体属生殖器gyrA 基因突变及其对莫西沙星耐药失败的影响:是时候进行下一代耐药指导治疗了。
Clin Infect Dis. 2023 Jun 16;76(12):2187-2195. doi: 10.1093/cid/ciad057.
10
The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic.细菌对抗环丙沙星的耐药机制和增强这种抗生素疗效的新方法。
Front Public Health. 2022 Dec 21;10:1025633. doi: 10.3389/fpubh.2022.1025633. eCollection 2022.